Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection (Q80572805)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 July 2007
edit
Language Label Description Also known as
English
Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection
scientific article published on 01 July 2007

    Statements

    Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit